Products Documents
RNA Interference Overview
Introduction to RNAi
Mechanism of RNAi
Applications of RNAi
RNAi Experiments
References

Basic Requirements
RNAi experiments have four basic requirements:

An effective RNAi “trigger”: a specific dsRNA that targets a particular gene transcript to induce the RNAi pathway. In mammalian cultured cells, RNAi is typically induced by siRNA or a short hairpin RNA (shRNA).

An efficient delivery method for the trigger: For mammalian cultured cells, the two most commonly used methods are transfection and electroporation. For many immortalized cell lines, transfection with a lipid- or amine-based reagent is the preferred option. Electroporation is used for delivery into primary cells and suspension cells for which standard transfection methodologies are problematic.

A robust phenotypic assay for the RNAi effect: Phenotypic assays are procedures that provide a quantitative measure of any state or condition of the cells in a population. Developing an assay with a high signal-to-noise ratio that truly measures the cellular phenotype is critical to the success of screening experiments using RNAi tools.

Positive and negative controls: Controls are needed both for siRNA delivery and for the phenotypic assay.

Mammalian RNAi Experiments
In mammalian cultured cells, RNAi is typically induced by the use of siRNAs. There are two general methods for producing siRNAs in cultured cells: delivery of synthetic siRNAs, and introduction of a DNA construct that expresses short hairpin RNA sequences (shRNA) that are processed to siRNAs within the cell (Figure 3). Figure 4 below summarizes the procedures and capabilities of each method (see also Downward 2004 [1], Silva et al. 2004 [59], Sachse et al. 2005 [3]).

Figure 3. Three Ways to Trigger the RNAi Pathway. (1) In non-mammalian systems, the RNAi pathway commences when double-stranded RNA (dsRNA; usually longer than 30 bp) is introduced into cells. In mammalian systems, RNAi can be triggered by DNA based expression vectors designed to express short hairpin RNA (shRNA) molecules (2) or by synthetic short interfering RNA (siRNA) molecules (3) . In each case, gene silencing results from destruction of mRNA that is complementary to the input siRNA (3) or the siRNA molecules created by Dicer cleavage of longer dsRNA (1) or shRNA (2) molecules.  Dicer=cytoplasmic nuclease; RISC=RNA-induced silencing complex; mRNA=messenger RNA.

Delivery of Synthetic siRNAs
Synthetic siRNAs are typically 21 bp double-stranded RNA molecules with dinucleotide 3' overhangs. Synthetic siRNAs are thought to load directly into RISC upon introduction into the cytoplasm by transfection or electroporation. The RNAi effect achieved is transient, lasting typically for 3–7 days.

Careful design of the siRNA is required to maximize silencing of the target gene while minimizing off-target effects. With improved understanding of the mechanism of RNAi, algorithms for designing effective siRNAs have improved concomitantly, decreasing the number of sequences that need to be tested to elicit gene-specific silencing. Nevertheless, good experimental design dictates independently testing multiple distinct siRNA sequences targeting the same transcript to confirm that observed gene silencing is due to specific rather than off-target effects.

The various methods for producing synthetic siRNAs are described below:

Chemical Synthesis
Chemical synthesis is the preferred and most widely used siRNA preparation method for transient experiments in cultured cells. Chemically synthesized siRNAs are easy to use and to transfect in many cell types, and are readily adaptable to high throughput screening methods.

In Vitro Transcription
siRNAs can be readily prepared by in vitro transcription (IVT) of synthetic DNA oligonucleotide templates, but this method requires more hands-on time from the researcher and is subject to higher variability in yield and quality of the products. Higher toxicity has been observed empirically in some cell lines using siRNAs synthesized by IVT.

In Vitro Transcription of Long dsRNA Followed By Cleavage With Dicer or RNase III
Long dsRNAs are prepared by IVT using a template that typically encodes a 200–1000 nt region of the target mRNA. The dsRNA is then digested in vitro with Dicer or RNase III to produce a population of endonuclease-prepared siRNAs (esiRNAs) or siRNA-like molecules, respectively. The product mixture, containing many different siRNAs, is then used to test gene knockdown, bypassing the testing steps involved in selecting an individual effective siRNA sequence. This method requires significant hands-on time and has complex scale-up requirements.

Expression of shRNA from a Plasmid or Viral Vector
Short hairpin RNA (shRNA), expressed from a plasmid or viral vector within the cell, can trigger RNAi. Although vector constructs are more labor intensive to use compared to chemically synthesized siRNAs, and vector-encoded siRNA design rules are not as well established, this method does provide a viable alternative when chemically synthesized siRNAs cannot be used. In addition, viral-based vectors permit delivery by infection, which can be beneficial if your cell system is very difficult or impossible to transfect with siRNAs (e.g., terminally differentiated cells).

If your experimental conditions require strong silencing for more than a week, a vector that can integrate into the host genome is a wise choice. Integration vector-based libraries also offer the potential of selective screens. In this approach, a selective pressure is applied to the cells to screen for RNAi targets that are required for sensitivity to the selection; only cells with constructs expressing shRNA to the required target survive and grow. This strategy has been used in a large-scale RNAi screen for genes involved in p53-dependent proliferation arrest [60].

A refinement of selective screens is aimed at identifying RNAi targets whose silencing would not permit survival of a selective screen—“barcode” screening [60, 61]. A gene-specific sequence, the barcode, is incorporated into each shRNA construct. Pools of shRNA constructs are introduced into cells, and subjected to a selective pressure. The shRNA representation in the pools before and after the selection is compared by amplification of the barcodes present in the pools with different fluorescent labels and hybridization to barcode microarrays. This as-yet not fully validated strategy has promise as a method for identifying genes with potential as therapeutic targets [1].

A major disadvantage of plasmid-based libraries for large-scale screens is the lower transfection efficiency of plasmids compared to oligonucleotides. Synthetic siRNAs must be delivered only to the cytoplasm, whereas plasmid vector constructs must enter the nucleus; viral vectors improve this delivery limitation. In addition, the labor and cost of preparing DNA for transfection from large numbers of plasmids is significant, and replication of bacterial cultures potentially subjects the bacteria carrying the plasmids to selective pressure for recombination events that lead to loss of hairpin sequences [1]. Also, the effective concentration of the shRNA that is expressed inside the cell may not be as readily controlled as that of synthetic siRNAs, which decreases the user’s control over the risk of off-target effects. Some groups report higher variability in effectiveness of silencing by shRNAs than by siRNAs [3].

Figure 4: Methods for Producing siRNAs and shRNAs

 

Chemical synthesis

In vitro transcription (IVT)

Dicer/RNase III digestion

Expression vector

Procedure

1. Order pre-designed siRNAs online

OR

1. Design siRNA and order custom siRNAs online

1. Design siRNAs

2. Order DNA oligonucleotides

3. Perform IVT reaction

4. Anneal

5. Treat with DNase and ssRNA- specific RNase

6. Perform column purification

1. Create transcription template

2. Perform IVT reaction

3. Anneal

4. Clean up dsRNA

5. Digest with

6. Dicer/RNase III

7. Purify

1. Design siRNAs

2. Order DNA oligonucleotides

3. Clone into linearized vector

4. Isolate clones

5. Verify sequence

6. Perform large scale prep

Requirements

Two 21-mer RNA oligonucleotides

Two 29-mer
DNA oligonucleotides

Transcription template (200–800 bp region flanked by promoters)

Two 55–60-mer DNA oligonucleotides

Ability to fluorescently label siRNA

Yes

Yes

Yes

No

(however some vectors code for Green Fluorescent Protein)

Useful for
long-term studies?

No

No

No

Yes, using certain vectors with antibiotic resistance markers

Ambion Product

Silencer® Pre-designed siRNA

Silencer® Validated siRNA

Silencer® Control siRNA

Silencer® siRNA Libraries

Silencer® CellReady™ siRNA Libraries

Custom siRNA Synthesis

Silencer® siRNA Construction Kit

Silencer® siRNA Cocktail Kit
(RNase III)

pSilencer™ siRNA Expression Vectors

pSilencer™ adeno 1.0-CMV System

pSilencer™ 5.1 Retro System


CLICK HERE for interactive, online version

Figure 5. siRNA Decision Tree: A Guide to Designing siRNA Experiments Determining which approach to use for an RNAi experiment in mammalian cultured cells begins with answering a few simple questions. The first question is whether you need long-term silencing. Transfection of siRNAs usually induces strong silencing for 3–7 days; the length of the effect depends on the proliferation rate of the cells and the potency of the siRNA. Most experiments can be completed in this amount of time. Although you can re-transfect cells to extend the RNAi effect, if your experiment requires more than a week of silencing, a vector-based approach may be a better choice.

Non-mammalian RNAi Experiments
As model systems for studying development and cell regulation, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster each offer powerful genetics, a completely sequenced genome, and a significant degree of gene conservation with vertebrates [53, 54]. In C. elegans and Drosophila, long dsRNA (e.g., typically >200 bp) complementary to the target transcript is used to induce RNAi (Figure 3).

RNAi is readily induced by feeding C. elegans with bacteria harboring plasmid constructs engineered to express dsRNA [19, 55] or by soaking the worms in dsRNA [18]. Both strategies are adaptable to large-scale, high throughput screens [56, 57].

In cultured Drosophila cells, large-scale screens using RNAi can be performed via transfection or “bathing” (adding dsRNA directly to the culture medium in which the cells are grown). Transfection is used in cell lines where bathing is not an efficient delivery method or when the screen uses transient transfection of reporter constructs [20]. Bathing has also been used in combination with transfection of reporter constructs [58].

Double-stranded RNA for direct delivery in either system is typically synthesized by bidirectional in vitro transcription of DNA templates representing either genomic fragments or open reading frames [20, 56, 57].

The availability and utility of genome-wide C. elegans and Drosophila RNAi libraries has moved RNAi-based research from the study of single genes to the identification of new genes involved in biological processes of interest. A similar transformation to functional genomics is occurring in mammalian systems now that genomic siRNA libraries are available.

Ambion Recommends:

The MEGAscript® High Yield Transcription Kit is the most frequently used in vitro transcription kit for producing large numbers of long dsRNA for RNAi in C. elegans and Drosophila.

The MEGAscript® RNAi Kit was developed specifically to generate dsRNA for RNAi by in vitro transcription. This kit is geared to production of small numbers of dsRNA.

Silencer® Drosophila RNAi Library provides ready-to-use dsRNA targeting Drosophila genes. The best annotated genes from the Drosophila genome are represented for genome-wide RNAi screening in Drosophila cells.

Definitions

Argonaute
Argonaute proteins are found in all RISC and miRNA-containing ribonucleoprotein complexes and have been shown to be the catalytic site of mRNA cleavage in RISC [47]. Argonautes are ~100 kDa proteins characterized by conserved domains called PAZ and PIWI. Argonautes can be organized by sequence into two subfamilies, Ago and Piwi, based on a higher degree of homology to either Arabidopsis AGO1 or to Drosophila Piwi. The Ago group functions in RNAi and miRNA silencing pathways. 

Cosuppression
Silencing of an endogenous gene caused by the introduction of a trans-gene or infection by a virus. This term, which can refer to silencing at the post-transcriptional (PTGS; post-transcriptional gene silencing) or transcriptional (TGS; transcriptional gene silencing) level, is used primarily by researchers working with plants. In Neurospora crassa, this phenomenon is known as quelling.

Dicer
A ~200 kDa multidomain, RNase III family enzyme that functions in processing dsRNA to siRNA and assembly of the guide strand into RISC. Dicer progressively cleaves dsRNA at 21–25 bp intervals to generate siRNAs with 2-nt 3' overhangs and phosphorylated 5' ends. The predicted structure of Dicer includes an ATPase/RNA helicase domain, a conserved PAZ domain that is shared with Argonaute, two catalytic RNase III domains, and a C-terminal dsRNA binding domain (dsRBD).

dsRNA
Double-stranded RNA

Guide Strand
The strand of the siRNA that is assembled with RISC and provides sequence specificity for target mRNA cleavage. The guide strand is in the anti-sense orientation with respect to the mRNA.

miRNA
MicroRNA, a large class of evolutionarily conserved, noncoding, RNA originating from longer transcripts characterized by imperfect hairpin structures. miRNAs are 19–23 nt RNAs processed from pre-miRNA precursors by Dicer, the same enzyme that processes siRNAs.

Passenger Strand
The strand of the siRNA that dissociates from the siRNA during assembly with RISC.

PAZ Domain
Conserved domain found in both Dicer and Argonaute. It is thought that the 3' end of the guide strand of an siRNA is in contact with the PAZ in RISC.

PIWI Domain
Conserved domain found in Argonaute and thought to be the catalytic site for mRNA cleavage. It is thought that the 5' end of the guide strand of the siRNA contacts the PIWI domain in RISC.

Post-transcriptional Gene Silencing (PTGS)
Silencing of an endogenous gene caused by the introduction of a homologous dsRNA, trans-gene or virus. In PTGS, the transcript of the silenced gene is synthesized but does not accumulate because it is rapidly degraded. This is a more general term than RNAi, since it can be triggered by several different means.

R2D2
A small, dsRNA binding protein that works with Dicer in assembly of siRNA with RISC.

rasiRNA
Repeat-associated siRNA, an endogenous form of siRNA that originates from repetitive elements within the genome.

RdRPs
RNA-dependent RNA Polymerases. RdRPs may play a role in amplifying RNA triggers for silencing. Although they are not found in insects and mammals, they are present in other eukaryotes that have RNA silencing pathways.

RISC
RNA-induced silencing complex. A nuclease complex, composed of proteins and siRNA, that targets and cleaves endogenous mRNAs complementary to the siRNA within the complex.

RITS
RNA-induced transcriptional silencing complex. A complex of proteins and rasiRNA that inhibits transcription of target DNA through heterochromatin formation. RITS contains at least one protein in common with RISC, Argonaute [49].

RNAi, RNA Interference
A process of mRNA cleavage and degradation that is induced by double-stranded RNA in a sequence-specific manner.

RNA Silencing
The collective term for the pathways that use small RNAs as guides to specifically modify expression of targeted genes or genomic regions.

RNase III Family
A group of double-stranded RNA-specific endonucleases characterized by production of dsRNA fragments with 2–3-nt 3' overhangs and 5' phosphorylated ends, similar to those produced by Dicer.

Small RNA
A collective term for siRNA, rasiRNA, and miRNA

siRNA
Short interfering RNA, siRNAs are 21–25 bp dsRNA with dinucleotide 3' overhangs that are processed from longer dsRNA by Dicer in the RNA interference pathway. Introduction of synthetic siRNAs can induce RNA interference in mammalian cells. siRNAs can also originate from endogenous dsRNA precursors.

shRNA
Short hairpin RNA. shRNAs are used in plasmid- or vector-based approaches for supplying siRNAs to cells to produce stable gene silencing. A strong promoter is used to drive transcription of a target sequence designed to form hairpins and loops of variable length, which are then processed to siRNAs by the cellular RNAi machinery.

siRISC
A term for RISC assembled with the guide strand of an siRNA.

 
Home | Products | Technical Resources | What's New | About Us | Contact Us
Advanced Search | Site Map | Privacy | Trademarks/Legal | Web Feedback | Jobs
© Applied Biosystems. All rights reserved.